GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Orexigen Therapeutics Inc (FRA:JXS1) » Definitions » Pretax Margin %

Orexigen Therapeutics (FRA:JXS1) Pretax Margin % : -110.19% (As of Sep. 2017)


View and export this data going back to . Start your Free Trial

What is Orexigen Therapeutics Pretax Margin %?

Pre-Tax margin is calculated as Pre-Tax Income divided by its Revenue. Orexigen Therapeutics's Pre-Tax Income for the three months ended in Sep. 2017 was €-17.48 Mil. Orexigen Therapeutics's Revenue for the three months ended in Sep. 2017 was €15.86 Mil. Therefore, Orexigen Therapeutics's pretax margin for the quarter that ended in Sep. 2017 was -110.19%.

The historical rank and industry rank for Orexigen Therapeutics's Pretax Margin % or its related term are showing as below:


FRA:JXS1's Pretax Margin % is not ranked *
in the Drug Manufacturers industry.
Industry Median: 4.12
* Ranked among companies with meaningful Pretax Margin % only.

Orexigen Therapeutics Pretax Margin % Historical Data

The historical data trend for Orexigen Therapeutics's Pretax Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Orexigen Therapeutics Pretax Margin % Chart

Orexigen Therapeutics Annual Data
Trend Dec07 Dec08 Dec09 Dec10 Dec11 Dec12 Dec13 Dec14 Dec15 Dec16
Pretax Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -2,628.33 -2,266.19 -67.59 -275.20 -72.36

Orexigen Therapeutics Quarterly Data
Mar13 Jun13 Sep13 Dec13 Mar14 Jun14 Sep14 Dec14 Mar15 Jun15 Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17 Apr18
Pretax Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -176.30 -360.85 -130.66 -110.19 -

Competitive Comparison of Orexigen Therapeutics's Pretax Margin %

For the Drug Manufacturers - Specialty & Generic subindustry, Orexigen Therapeutics's Pretax Margin %, along with its competitors' market caps and Pretax Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Orexigen Therapeutics's Pretax Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Orexigen Therapeutics's Pretax Margin % distribution charts can be found below:

* The bar in red indicates where Orexigen Therapeutics's Pretax Margin % falls into.



Orexigen Therapeutics Pretax Margin % Calculation

Pretax margin - also known as pretax profit margin is the ratio of Pretax Income divided by net sales or Revenue, usually presented in percent.

Orexigen Therapeutics's Pretax Margin for the fiscal year that ended in Dec. 2016 is calculated as

Pretax Margin=Pre-Tax Income (A: Dec. 2016 )/Revenue (A: Dec. 2016 )
=-23.123/31.956
=-72.36 %

Orexigen Therapeutics's Pretax Margin for the quarter that ended in Sep. 2017 is calculated as

Pretax Margin=Pre-Tax Income (Q: Sep. 2017 )/Revenue (Q: Sep. 2017 )
=-17.476/15.86
=-110.19 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Orexigen Therapeutics  (FRA:JXS1) Pretax Margin % Explanation

The pretax margin, as know as pretax profit margin, is widely used to measure the operating efficiency of a company before deducting taxes.

The pretax margin is sometimes preferred over the net margin as tax expenditures can make profitability comparisons between companies misleading.

It is a useful tool to compare companies operating in the same sector and less effective when comparing companies from other sectors as each industry generally has different operating expenses and sales patterns.

The long term trend of the pretax margin is a good indicator of the competitiveness and health of the business.


Orexigen Therapeutics Pretax Margin % Related Terms

Thank you for viewing the detailed overview of Orexigen Therapeutics's Pretax Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Orexigen Therapeutics (FRA:JXS1) Business Description

Traded in Other Exchanges
N/A
Address
3344 North Torrey Pines Court, Suite 200, La Jolla, CA, USA, 92037
Orexigen is an emerging pharmaceutical company, focusing on developing neuroscience drugs. The company screens older drugs seeking synergistic actions. The company's most advanced drug candidates target obesity.

Orexigen Therapeutics (FRA:JXS1) Headlines

No Headlines